Centralized multidisciplinary team assessment of metastasis resectability in patients with metastatic colorectal cancer: A fundamental necessity

por André, Thierry
Publicado 2021

Immunotherapy for Early Stage Colorectal Cancer: A Glance into the Future

por Cohen, Romain, Shi, Qian, André, Thierry
Publicado 2020

Letter to the Editor from Colle et al

por Colle, Raphael, Andre, Thierry, Menu, Yves
Publicado 2021

Molecular Targets for the Treatment of Metastatic Colorectal Cancer

por Cohen, Romain, Pudlarz, Thomas, Delattre, Jean-François, Colle, Raphaël, André, Thierry
Publicado 2020

Long-Term Survival in Locally Advanced KRAS Wild-Type Pancreatic Adenocarcinoma

por Alhenc-Gelas, Marion, Cohen, Romain, Cervera, Pascale, Vaillant, Jean-Christophe, André, Thierry
Publicado 2019

A Correlative Study of Sunflower Seed Vigor Components as Related to Genetic Background

por Saux, Marine, Bleys, Benoît, André, Thierry, Bailly, Christophe, El-Maarouf-Bouteau, Hayat
Publicado 2020

Immune Checkpoint Inhibition in Metastatic Colorectal Cancer Harboring Microsatellite Instability or Mismatch Repair Deficiency

por Cohen, Romain, Colle, Raphaël, Pudlarz, Thomas, Heran, Maximilien, Duval, Alex, Svrcek, Magali, André, Thierry
Publicado 2021

A randomized phase II study of weekly nab-paclitaxel plus gemcitabine or simplified LV5FU2 as first-line therapy in patients with metastatic pancreatic cancer: the AFUGEM GERCOR tr...

por Bachet, Jean-Baptiste, Chibaudel, Benoist, Bonnetain, Franck, Validire, Pierre, Hammel, Pascal, André, Thierry, Louvet, Christophe
Publicado 2015

Association of post-operative CEA with survival and oxaliplatin benefit in patients with stage II colon cancer: a post hoc analysis of the MOSAIC trial

por Auclin, Edouard, André, Thierry, Taieb, Julien, Banzi, Maria, Van Laethem, Jean-Luc, Tabernero, Josep, Hickish, Tamas, de Gramont, Aimery, Vernerey, Dewi
Publicado 2019

Analysis of neurosensory adverse events induced by FOLFOX4 treatment in colorectal cancer patients: a comparison between two Asian studies and four Western studies

por Sugihara, Kenichi, Ohtsu, Atsushi, Shimada, Yasuhiro, Mizunuma, Nobuyuki, Gomi, Katsushige, Lee, Po-Huang, Gramont, Aimery, Rothenberg, Mace L, André, Thierry, Brienza, Silvano, Goldberg, Richard M
Publicado 2012

Time to Definitive Health-Related Quality of Life Score Deterioration in Patients with Resectable Metastatic Colorectal Cancer Treated with FOLFOX4 versus Sequential Dose-Dense FOL...

por Hamidou, Zeinab, Chibaudel, Benoist, Hebbar, Mohamed, Hug de Larauze, Marine, André, Thierry, Louvet, Christophe, Brusquant, David, Garcia-Larnicol, Marie-Line, de Gramont, Aimery, Bonnetain, Franck
Publicado 2016

Ovarian metastases of pancreatic adenocarcinoma: clinical presentation, role of surgery, and potential value of the mutational profile for the differential diagnosis with primary m...

por de Malet, Alice, Svrcek, Magali, Kerbaol, Anne, Theou-Anton, Nathalie, Granier, Sandra, Dokmak, Safi, Paye, François, André, Thierry, de Mestier, Louis, Cros, Jérôme, Hammel, Pascal
Publicado 2021

Treatments after Immune Checkpoint Inhibitors in Patients with dMMR/MSI Metastatic Colorectal Cancer

por Bui, Quang Loc, Mas, Léo, Hollebecque, Antoine, Tougeron, David, de la Fouchardière, Christelle, Pudlarz, Thomas, Alouani, Emily, Guimbaud, Rosine, Taieb, Julien, André, Thierry, Colle, Raphaël, Cohen, Romain
Publicado 2022

The IDEA (International Duration Evaluation of Adjuvant Chemotherapy) Collaboration: Prospective Combined Analysis of Phase III Trials Investigating Duration of Adjuvant Therapy wi...

por André, Thierry, Iveson, Timothy, Labianca, Roberto, Meyerhardt, Jeffrey A., Souglakos, Ioannis, Yoshino, Takayuki, Paul, James, Sobrero, Alberto, Taieb, Julien, Shields, Anthony F., Ohtsu, Atsushi, Grothey, Axel, Sargent, Daniel J.
Publicado 2013

STRATEGIC-1: A multiple-lines, randomized, open-label GERCOR phase III study in patients with unresectable wild-type RAS metastatic colorectal cancer

por Chibaudel, Benoist, Bonnetain, Franck, Tournigand, Christophe, de Larauze, Marine Hug, de Gramont, Armand, Laurent-Puig, Pierre, Paget, Jérôme, Hadengue, Alexandra, Notelet, Dominique, Benetkiewicz, Magdalena, André, Thierry, de Gramont, Aimery
Publicado 2015

BRAF (V600E)/RAS Mutations and Lynch Syndrome in Patients With MSI-H/dMMR Metastatic Colorectal Cancer Treated With Immune Checkpoint Inhibitors

por Colle, Raphael, Lonardi, Sara, Cachanado, Marine, Overman, Michael J, Elez, Elena, Fakih, Marwan, Corti, Francesca, Jayachandran, Priya, Svrcek, Magali, Dardenne, Antoine, Cervantes, Baptiste, Duval, Alex, Cohen, Romain, Pietrantonio, Filippo, André, Thierry
Publicado 2023

Survival, safety, and prognostic factors for outcome with Regorafenib in patients with metastatic colorectal cancer refractory to standard therapies: results from a multicenter stu...

por Adenis, Antoine, de la Fouchardiere, Christelle, Paule, Bernard, Burtin, Pascal, Tougeron, David, Wallet, Jennifer, Dourthe, Louis-Marie, Etienne, Pierre-Luc, Mineur, Laurent, Clisant, Stéphanie, Phelip, Jean-Marc, Kramar, Andrew, Andre, Thierry
Publicado 2016

Erratum to: Survival, safety, and prognostic factors for outcome with Regorafenib in patients with metastatic colorectal cancer refractory to standard therapies: results from a mul...

por Adenis, Antoine, de la Fouchardiere, Christelle, Paule, Bernard, Burtin, Pascal, Tougeron, David, Wallet, Jennifer, Dourthe, Louis-Marie, Etienne, Pierre-Luc, Mineur, Laurent, Clisant, Stéphanie, Phelip, Jean-Marc, Kramar, Andrew, Andre, Thierry
Publicado 2016

RECIST and CHOI criteria in the evaluation of tumor response in patients with metastatic colorectal cancer treated with regorafenib, a prospective multicenter study

por Lucidarme, Olivier, Wagner, Mathilde, Gillard, Paul, Kim, Stefano, Bachet, Jean-Baptiste, Rousseau, Benoit, Mazard, Thibault, Louvet, Christophe, Chibaudel, Benoist, Cohen, Romain, Garcia-Larnicol, Marie-Line, Gobert, Aurelien, Henriques, Julie, André, Thierry
Publicado 2019

Monitoring levels of circulating cell‐free DNA in patients with metastatic colorectal cancer as a potential biomarker of responses to regorafenib treatment

por Pastor, Brice, André, Thierry, Henriques, Julie, Trouilloud, Isabelle, Tournigand, Christophe, Jary, Marine, Mazard, Thibault, Louvet, Christophe, Azan, Simon, Bauer, Audrey, Roch, Benoit, Sanchez, Cynthia, Vernerey, Dewi, Thierry, Alain R., Adenis, Antoine
Publicado 2021